Bone Biologics (BBLG) Accumulated Expenses (2010 - 2021)
Bone Biologics (BBLG) reported Accumulated Expenses of $2.1 million for Q4 2021, up 713.48% year-over-year from $252500.0 in Q4 2020, and up 590.43% quarter-over-quarter from $297500.0 in Q3 2021.
Bone Biologics (BBLG) Accumulated Expenses (2010 - 2021) Analysis & Trends
Bone Biologics (BBLG) has 12 years of Accumulated Expenses data on file, last reported at $2.1 million in Q4 2021.
- Accumulated Expenses for Q4 2021 came in at $2.1 million, up 713.48% year-over-year; the trailing twelve-month figure through Dec 2021 was $2.1 million (up 713.48% YoY), and the FY2021 annual result was $2.1 million, up 713.48% from the prior year.
- Accumulated Expenses rose to $2.1 million in Q4 2021 per BBLG's latest filing, from $297500.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $2.1 million in Q4 2021 and troughed at $62225.0 in Q2 2018.
- A 5-year average of $520497.7 and a median of $272083.5 in 2018 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2019 and 2020: Accumulated Expenses tumbled 79.73% in 2019, then surged 1079.6% in 2020.
- A 5-year view of Accumulated Expenses shows it stood at $456000.0 in 2017, then retreated by 3.14% to $441667.0 in 2018, then plunged by 79.73% to $89517.0 in 2019, then soared by 182.07% to $252500.0 in 2020, then surged by 713.48% to $2.1 million in 2021.
- Business Quant data shows BBLG's Accumulated Expenses at $2.1 million in Q4 2021, $297500.0 in Q3 2021, and $1.8 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 297,500.00 |
| Jun 30, 2021 | 1.76 Mn |
| Mar 31, 2021 | 1.50 Mn |
| Dec 31, 2020 | 252,500.00 |
| Sep 30, 2020 | 1.00 Mn |
| Jun 30, 2020 | 756,122.00 |
| Mar 31, 2020 | 207,500.00 |
| Dec 31, 2019 | 89,517.00 |
| Sep 30, 2019 | 85,143.00 |
| Jun 30, 2019 | 162,500.00 |
| Mar 31, 2019 | 491,667.00 |
| Dec 31, 2018 | 441,667.00 |
| Sep 30, 2018 | 67,642.00 |
| Jun 30, 2018 | 62,225.00 |
| Mar 31, 2018 | 291,667.00 |
| Dec 31, 2017 | 456,000.00 |
| Sep 30, 2017 | 191,667.00 |
| Jun 30, 2017 | 141,667.00 |
| Mar 31, 2017 | 91,667.00 |